Gland Pharma informs about annual secretarial compliance report

27 May 2025 Evaluate
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Gland Pharma has enclosed the Secretarial Compliance Report for the financial year ended 31st March, 2025 issued by RVR & Associates, Company Secretaries. 

The above information is a part of company’s filings submitted to BSE.


Gland Pharma Share Price

1704.25 -49.65 (-2.83%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×